Nephrin Antibody - BSA Free

Immunohistochemistry: Nephrin Antibody - BSA Free [NBP1-77303]

Immunohistochemistry: Nephrin Antibody - BSA Free [NBP1-77303] - Nephrin Antibody [NBP1-77303] - Staining of rat kidney tissue with antibody at 5 ug/mL.

Western Blot: Nephrin AntibodyBSA Free [NBP1-77303]

Western Blot: Nephrin Antibody - BSA Free [NBP1-77303] - Nephrin Antibody [NBP1-77303] - Mouse kidney tissue lysate with Nephrin antibody at 1 u/mL in the (A) absence and (B) presence of blocking peptide.

Immunocytochemistry/ Immunofluorescence: Nephrin Antibody - BSA Free [NBP1-77303] -

Immunocytochemistry/ Immunofluorescence: Nephrin Antibody - BSA Free [NBP1-77303] - In vivo AS-IV effects on podocyte EMT. alpha-SMA & nephrin levels in vivo were analyzed by immunofluorescence assay & the levels of TGF-beta, N-cadherin & E-cadherin were quantified using Western blotting. Data is presented as mean ± SD. n = 3. *Compared with normal control cohort, or AS-IV treated cohort, P < 0.05. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/30674969), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: Nephrin Antibody - BSA Free [NBP1-77303] -

Western Blot: Nephrin Antibody - BSA Free [NBP1-77303] - AS-IV effects on hyperglycaemia-triggered podocyte EMT. (A) AS-IV chemical structure. (B–E) Podocytes were pretreated with high/normal glucose for 1 hour, & then incubated with or without AS-IV (25, 50 & 100 μM) for 48 hours. (B) mRNA expression levels of TGF-beta were detected using real-time PCR. (C) TGF-beta protein levels were quantified using Western blotting. (D) mRNA expression levels of alpha-SMA, N-cadherin, E-cadherin & nephrin were detected using real-time PCR. (E) Protein levels of alpha-SMA, N-cadherin, E-cadherin & nephrin were detected using Western blotting. Note: E-Ca, E-cadherin; N-Ca, N-cadherin. The molecular weight of the proteins: TGF-beta, 44 kDa; nephrin, 100 kDa; E-cadherin, 110 kDa; N-cadherin, 100 kDa; alpha-SMA, 42 kDa. Data is presented as mean ± SD. n = 3. *Compared with normal glucose cohort or AS-IV cohort, P < 0.05; #compared with high glucose cohort, P < 0.05. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/30674969), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: Nephrin Antibody - BSA Free [NBP1-77303] -

Western Blot: Nephrin Antibody - BSA Free [NBP1-77303] - In vitro AS-IV effects on SIRT1 & NF-kB p65 expression in hyperglycaemia-triggered podocyte EMT. (A–F) Podocytes were exposed to either a SIRT1 inhibitor EX527 or SIRT1 activator SRT1720 after a 1 hour exposure to hyperglycaemic conditions, & were subsequently incubated with or without AS-IV (100 μM) for 48 hours. (A,E) mRNA expression levels of SIRT1and p65 were quantified using real-time PCR. (B) The deacetylase activity of SIRT1 was detected with a SIRT1 activity assay. (C,D,F) The protein levels of SIRT1 & AC-p65 were quantified using Western blotting. The molecular weight of the proteins: SIRT1, 110 kDa; AC-p65, 65 kDa; p65, 65 kDa. Data is presented as mean ± SD. n = 3. *Compared with normal glucose cohort, or AS-IV cohort, or high glucose plus AS-IV cohort, or high glucose plus SRT1720 cohort, P < 0.05; #compared with high glucose plus AS-IV cohort, P < 0.05. (G) Podocytes were pretreated with high glucose for 1 hour, & then incubated with PDTC or AS-IV for 48 hours. The levels of TGF-beta, nephrin, E-cadherin, N-cadherin & alpha-SMA were quantified with Western blotting. Data is presented as mean ± SD. n = 3. *Compared with normal glucose cohort, or high glucose plus AS-IV cohort, or high glucose plus PDTC cohort, P < 0.05. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/30674969), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunohistochemistry: Nephrin Antibody - BSA Free [NBP1-77303] -

Immunohistochemistry: Nephrin Antibody - BSA Free [NBP1-77303] - Validation of Nephrin in Mouse Kidney Tissue. Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti- Nephrin antibody at 1 ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Immunocytochemistry/ Immunofluorescence: Nephrin Antibody - BSA Free [NBP1-77303] -

Immunocytochemistry/ Immunofluorescence: Nephrin Antibody - BSA Free [NBP1-77303] - Validation of Nephrin in Mouse Kidney Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse kidney cells labeling Nephrin with at 10 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).

Immunocytochemistry/ Immunofluorescence: Nephrin Antibody - BSA Free [NBP1-77303] -

Immunocytochemistry/ Immunofluorescence: Nephrin Antibody - BSA Free [NBP1-77303] - Validation of Nephrin in Rat Kidney Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed rat kidney tissue labeling Nephrin with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).